The traditional M1/M2 paradigm suggests that M1 macrophages, induced by IFN-γ, TNF-α, and TLR signaling, promote anti-tumor immunity through the production of pro-inflammatory cytokines and reactive oxygen species. The gene discussed is IFNG; the disease is neoplasm.